Heart Failure Archives

SGLT-2 Inhibitors Show Benefit in Heart Failure With Preserved Ejection Fraction

By

Sheila Jacobs

September 21, 2022

Investigators conducted a meta-analysis of randomized controlled trials on the effect of SGLT-2 inhibitors on patients with HFpEF.

Cardiology

Dapagliflozin Beneficial Regardless of Ejection Fraction in Heart Failure

By

Brian Park, PharmD

August 30, 2022

The findings were consistent across key subgroups examined (eg, LVEF<60%, diabetes)

Cardiology

Sotagliflozin Under Review for Heart Failure Treatment

By

Brian Park, PharmD

July 27, 2022

Sotagliflozin is an investigational dual sodium-glucose co-transporter types 1 and 2 (SGLT1, SGLT2) inhibitor.

Cardiology

Obesity Linked to Heart Failure in Women With Late Menopause

By

Sheila Jacobs

May 27, 2022

A study was conducted to determine the relationship between obesity, age at menopause, and heart failure incidence.

Cardiology

During the Pandemic, Telemedicine Follow-up for Heart Failure Improved 30-Day Outcomes

By

Jessica Nye, PhD

March 29, 2022

A study examined if early outpatient follow-up via telemedicine reduces 30-day readmission in patients with heart failure as effectively as in-person follow-up.

News

Mavacamten Evaluated in Patients With Obstructive Hypertrophic Cardiomyopathy Eligible for SRT

By

Brian Park, PharmD

February 17, 2022

The VALOR-HCM trial evaluated the effects of mavacamten in over 100 patients with symptomatic obstructive HCM (NYHA class III-IV) who met the guideline criteria for SRT and had been referred for an invasive procedure.